{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:12:43Z","timestamp":1761959563947,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"vor","delay-in-days":96,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.lrr.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T12:38:49Z","timestamp":1523277529000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)"],"prefix":"10.1016","volume":"9","author":[{"given":"Peter D.","family":"Whooley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell K.","family":"Dorer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Estimates of global cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lrr.2018.04.003_bib2","unstructured":"Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995\u20132010, Custom File With County, ACS Facts and Figures Projection Project. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013."},{"key":"10.1016\/j.lrr.2018.04.003_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6004\/jnccn.2016.0023","article-title":"Diffuse large B-cell lymphoma version 1.2016","volume":"14","author":"Zelenetz","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.lrr.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1200\/JCO.2005.05.015","article-title":"State-of-the-art therapeutics: diffuse large B-cell lymphoma","volume":"23","author":"Coiffier","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00063198-200107000-00011","article-title":"Mediastinal tumors","volume":"7","author":"Yoneda","year":"2001","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-016-0425-1","article-title":"Circulating tumor DNA to monitor therapy for aggressive B-cell lymphomas","volume":"17","author":"Kwok","year":"2016","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/MD.0000000000000121","article-title":"Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature","volume":"93","author":"London","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.lrr.2018.04.003_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/2278-330X.126531","article-title":"Management of relapsed-refractory diffuse large B cell lymphoma","volume":"3","author":"Raut","year":"2014","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.lrr.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib12","unstructured":"A. Goodman, January 25). CAR T-cell therapy KTE-C19 appears successful in aggressive B-Cell lymphoma. Retrieved September 8, 2017, from \u3008http:\/\/www.ascopost.com\/issues\/january-25-2017\/car-t-cell-therapy-kte-c19-appears-successful-in-aggressive-b-cell-lymphoma\/\u3009."},{"key":"10.1016\/j.lrr.2018.04.003_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1182\/asheducation-2017.1.284","article-title":"Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?","volume":"2017","author":"Davies","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.lrr.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","article-title":"Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma","volume":"32","author":"Thompson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-010-1044-8","article-title":"The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma","volume":"90","author":"Goldschmidt","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.lrr.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","article-title":"Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study","volume":"33","author":"El-Galaly","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3324\/haematol.10798","article-title":"Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma","volume":"92","author":"Zinzani","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-006-0167-4","article-title":"Unsuspected FDG-PET findings in the follow-up of patients with lymphoma","volume":"86","author":"Sonet","year":"2007","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.lrr.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: the Lugano Classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.2014.60.1120","article-title":"Does surveillance imaging after treatment for diffuse large B-cell lymphoma really work?","volume":"33","author":"Abel","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pon.955","article-title":"Cancer-related health worries and psychological distress among older adult, long-term cancer survivors","volume":"15","author":"Deimling","year":"2006","journal-title":"Psychooncology"},{"key":"10.1016\/j.lrr.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23423","article-title":"Strikingly high false positivity of surveillance FDG-PET\/CT scanning among patients with diffuse large cell lymphoma in the rituximab era","volume":"88","author":"Avivi","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2018.04.003_bib23","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography--an increasing source of radiation exposure","volume":"357","author":"Brenner","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.lrr.2018.04.003_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-14-153","article-title":"Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis","volume":"14","author":"He","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lrr.2018.04.003_bib26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2018.04.003_bib27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib28","first-page":"896","article-title":"Unexplained lymphadenopathy: evaluation and differential diagnosis","volume":"94","author":"Gaddey","year":"2016","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.lrr.2018.04.003_bib29","first-page":"1016","article-title":"The fear of lymphoadenopathy: does it portend sarcoidosis or lymphoma?","volume":"56","author":"Solbes","year":"2016","journal-title":"Consultant 360"},{"key":"10.1016\/j.lrr.2018.04.003_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1754-9485.2010.02179.x","article-title":"Enlarged hilar and mediastinal lymph nodes in chronic obstructive pulmonary disease","volume":"54","author":"Kirchner","year":"2010","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"10.1016\/j.lrr.2018.04.003_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/028418519303400513","article-title":"Reactive mediastinal lymphadenopathy in bronchiectasis assessed by CT","volume":"34","author":"Thomas","year":"1993","journal-title":"Acta Radiol."},{"key":"10.1016\/j.lrr.2018.04.003_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1378\/chest.119.2.653","article-title":"Benign mediastinal lymphadenopathy in congestive heart failure","volume":"119","author":"Ngom","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.lrr.2018.04.003_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"305","author":"Iannuzzi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.lrr.2018.04.003_bib34","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lrr.2018.04.003_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000076534","article-title":"Neurosarcoidosis: clinical experience and diagnostic pitfalls","volume":"51","author":"Kellinghaus","year":"2004","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.lrr.2018.04.003_bib36","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lrr.2018.04.003_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/bjc.1986.199","article-title":"The sarcoidosis-lymphoma syndrome","volume":"54","author":"Brincker","year":"1986","journal-title":"Br. J. Cancer"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:11Z","timestamp":1761959291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048918300062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":37,"alternative-id":["S2213048918300062"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2018.04.003","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}